Michelle Robertson Editas Medicine, Inc. (EDIT) insider trading activity

Michelle Robertson is EVP, CHIEF FINANCIAL OFFICER of Editas Medicine, Inc.. Currently has a direct ownership of 106,610 shares of EDIT, which is worth approximately $382,729. The most recent transaction as insider was on May 11, 2023, when has been sold 949 shares (Common Stock) at a price of $9.87 per share, resulting in proceeds of $9,366. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 107K

0% 3M change

0% 12M change

Total Value Held $382,729

MICHELLE ROBERTSON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 11 2023	SELL Open market or private sale	$9,366 $9.87 p/Share	949 Reduced 0.88%	106,610 Common Stock
Mar 03 2023	SELL Open market or private sale	$1,635 $8.89 p/Share	184 Reduced 0.17%	107,559 Common Stock
Mar 02 2023	BUY Grant, award, or other acquisition	-	31,500 Added 22.62%	107,743 Common Stock
Feb 13 2023	SELL Open market or private sale	$41,455 $9.67 p/Share	4,287 Reduced 5.32%	76,243 Common Stock
Jan 10 2023	SELL Open market or private sale	$14,296 $8.16 p/Share	1,752 Reduced 2.13%	80,530 Common Stock
Dec 05 2022	SELL Open market or private sale	$1,974 $10.23 p/Share	193 Reduced 0.23%	82,282 Common Stock
Sep 06 2022	SELL Open market or private sale	$2,882 $15.01 p/Share	192 Reduced 0.23%	82,475 Common Stock
Jun 03 2022	SELL Open market or private sale	$17,622 $11.54 p/Share	1,527 Reduced 1.81%	82,667 Common Stock
Mar 03 2022	SELL Open market or private sale	$13,292 $17.33 p/Share	767 Reduced 0.9%	84,194 Common Stock
Feb 10 2022	BUY Grant, award, or other acquisition	-	53,499 Added 38.64%	84,961 Common Stock
Jan 11 2022	SELL Open market or private sale	$44,821 $25.7 p/Share	1,744 Reduced 5.25%	31,462 Common Stock
Dec 22 2021	BUY Grant, award, or other acquisition	-	4,471 Added 11.87%	33,206 Common Stock
Aug 09 2021	SELL Open market or private sale	$150,000 $60.0 p/Share	2,500 Reduced 8.0%	28,735 Common Stock
Aug 09 2021	BUY Exercise of conversion of derivative security	$76,625 $30.65 p/Share	2,500 Added 7.41%	31,235 Common Stock
Jun 28 2021	SELL Open market or private sale	$125,000 $50.0 p/Share	2,500 Reduced 8.0%	28,735 Common Stock
Jun 28 2021	BUY Exercise of conversion of derivative security	$76,625 $30.65 p/Share	2,500 Added 7.41%	31,235 Common Stock
Mar 02 2021	BUY Grant, award, or other acquisition	-	10,303 Added 26.39%	28,735 Common Stock
Jan 12 2021	SELL Open market or private sale	$122,727 $78.27 p/Share	1,568 Reduced 7.84%	18,432 Common Stock

Also insider at

VSTM

Verastem, Inc. Healthcare

Director

GERN

GERON CORP Healthcare

EVP, Chief Financial Officer